Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas
- 43 Downloads
- 2 Citations
Abstract
Increased aldosterone secretion has been found in a mouse lacking the KCNE1 gene which codes for a regulatory protein of the KCNQ1 gene product, forming the channel for the outward rectifying delayed K+ current. Abnormalities in proteins regulating the K+ fluxes across membranes may be responsible for aldosterone-secreting adenomas (aldosteronomas) also because K+ channels are involved in cell growth. Normal and adenomatous adrenal samples and NCI-H295 cell line were used to: a) evaluate KCNE1 and KCNQ1 gene expression, b) sequence the full length cD-NAs of KCNE1 and both KCNQ1 isoforms. These differently spliced KCNE1 and KCNQ1 mRNAs were expressed in adrenal tissue. In contrast, KC-NQ1 isoform 2 mRNA was not expressed in kidney control tissues and NCI-H295 cell line. NCI-H295 cell line also had a significantly lower expression of KCNQ1 isoform 1 mRNA than normal adrenals and aldosteronomas. We did not find any somatic mutations in the coding sequences of both genes. This different expression pattern of KCNQ1 isoforms in NCI-H295 cell line with the lack of the mRNA for the dominant-negative KCNQ1 isoform 2 supports the involvement of voltage-gated K+ channel in cell proliferation.
En]Keywords
Aldosterone secreting adenomas KCNQ1 KCNE1Preview
Unable to display preview. Download preview PDF.
References
- 1.Davies E, Bonnardeaux A, Plouin PF, Corvol P, Clauser E. Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab 1995, 82: 611–5.Google Scholar
- 2.Romey G, Attali B, Chouabe C, et al. Molecular mechanism and functional significance of the MinK control of the Kv-LQT1 channel activity. J Biol Chem 1997, 272: 1671 3–6.Google Scholar
- 3.Sanguinetti MC. Maximal function of minimal K+ channels subunits. Trends Pharmacol Sci 2000, 21: 199–201.PubMedCrossRefGoogle Scholar
- 4.Sarzani R, Opocher G, Dessl Fulgheri P, et al. Expression of type 1 angiotensin II receptors in human aldosteronomas. Endoc Res 1995, 21: 189–95.CrossRefGoogle Scholar
- 5.Mazzocchi G, Malendowicz LK, Markowska A, Albertin G, Nussdorfer G. Role of adrenal renin — angiotensin system in the control of aldosterone secretion in sodium restricted rats. American Journal of Physiology. Am J Physiol Endocrinol Metab 2000, 278: E1027–30.Google Scholar
- 6.Sarzani R, Opocher G, Paci MV, et al. Natriuretic peptides receptors in human aldosterone-secreting adenomas. J Endocrinol Invest 1999, 22: 514–8.PubMedGoogle Scholar
- 7.Sarzani R, Salvi F, Pietrucci F, et al. Absence of somatic mutations in natriuretic peptide receptor type-A gene in human aldosterone-secreting adenomas. J Mol Endocrinol 2003, 31: 317–26.PubMedCrossRefGoogle Scholar
- 8.Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649–51.Google Scholar
- 9.Parma J, Duprez L, Van Sande J, et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 1997, 82: 2695–701.PubMedGoogle Scholar
- 10.Ballare E, Mantovani S, Lania A, et al. Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone secreting tumors. J Clin Endocrinol Metab 1997, 80: 4184–8.Google Scholar
- 11.Casimiro MC, Knollmann BC, Ebert SN, et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen syndrome. Proc Natl Acad Sci U S A 1998: 2526–31.Google Scholar
- 12.Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of K(v)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996, 84: 80–3.CrossRefGoogle Scholar
- 13.Suessbrich H, Busch AE. The Isk channel: coassembly onf Isk (minK) and KVLQT1 proteins. Rev Physiol Biochem Pharmacol 1999, 137: 191–26.PubMedGoogle Scholar
- 14.Arrighi I, Bloch-Faure M, Grahammer F, et al. Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. Proc Natl Acad Sci U S A 2001, 98: 8792–7.PubMedCentralPubMedCrossRefGoogle Scholar
- 15.Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three Long QT Syndromes genes: KVLQT1, HERG and KCNE1. Genomics 1998, 5186–97.Google Scholar
- 16.Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G 1996 K(v)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384: 78–80.PubMedCrossRefGoogle Scholar
- 17.Murray A, Donger C, Fenske C, et al. Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation 1999, 100: 1077–84.PubMedCrossRefGoogle Scholar
- 18.Demolombe S, Baró I, Péréon Y, et al. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998, 273: 6837–43.PubMedCrossRefGoogle Scholar
- 19.Jiang M, Tseng-Crank J, Tseng GN. Suppression of slow delayed rectifier current by a truncated isoform of KVLQT1 cloned from normal human heart. J Biol Chem 1997, 272: 24109–12.PubMedCrossRefGoogle Scholar
- 20.Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY, Blanar MA. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A 1997, 94: 4017–21.PubMedCentralPubMedCrossRefGoogle Scholar
- 21.Sarzani R, Fallo F, Dessl Fulgheri P, et al. Local renin — angiotensin system in human adrenals and aldosteronomas. Hypertension 1992, 19: 702–7.PubMedCrossRefGoogle Scholar
- 22.Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156–9.PubMedCrossRefGoogle Scholar
- 23.Sarzani R, Pietrucci F, Francioni M, et al. Human aldosterone secreting adenoma specifically express dominant negative KC-NQ1 isoform 2 mRNA. Hypertension 2003, p. 638 (abstract).Google Scholar
- 24.Zhou Q, Kwan HY, Chan HC, Jiang JL, Tam SC, Yao X. Blockage of voltage-gated K+ channels inhibits adhesion ad proliferation of hepatocarcinoma cells. Int J Mol Med 2003, 11: 261–6.PubMedGoogle Scholar
- 25.Abdul M, Santo A, Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res 2003, 23: 3347–51.PubMedGoogle Scholar
- 26.Crociani O, Guasti L, Balzi M, et al. Cell cycle-dependent expression of HERG1 and HERG1 B isoforms in tumor cells. J Biol Chem 2003, 278: 2947–55.PubMedCrossRefGoogle Scholar
- 27.Abdul M, Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002, 186: 99–105.PubMedCrossRefGoogle Scholar
- 28.Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 2002, 9: 961–4.PubMedGoogle Scholar
- 29.Sakai H, Shimizu T, Hori K, Ikari A, Asano S, Takeguchi N. Molecular and pharmacological properties of inwardly rectifying K+ channels of human lung cancer cells. Eur J Pharmacol 2002, 435: 125–33.PubMedCrossRefGoogle Scholar